CORONACORONA Remedies Limited
Convert to ideaHealthcare · Pharmaceuticals · CARE: A+ (Stable)
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeUp 0.5 this quarter.
Momentum from moving averages, Supertrend and RSI.
2 forensic issues found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
2 found · risk elevated
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹441 Cr | ₹60 Cr | 18.34% | 13.67% | ₹9.86 | 30.3x |
| Q1 FY2027 | ₹422 Cr | ₹60 Cr | 18.91% | 14.23% | ₹9.83 | 30.9x |
| Q4 FY2026 | ₹353 Cr | ₹45 Cr | 14.65% | 12.84% | ₹7.41 | 40.7x |
| Q3 FY2026 | ₹342 Cr | ₹41 Cr | 21.53% | 12.05% | ₹6.75 | 34.3x |
| Q2 FY2026 | ₹361 Cr | ₹52 Cr | 19.18% | 14.49% | ₹8.55 | 37.1x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Pharmaceuticals
Compare with peers →CORONA Remedies Limited, a pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products. It provides products in women's healthcare, cardio-diabeto, pain management, urology, thyroid management, respiratory, gastroenterology, and other therapeutic areas. The company was incorporated in 2004 and is based in Ahmedabad, India.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.